Longevity Supplements: What the Evidence Actually Supports (2026)

The longevity supplement market is projected to exceed $60 billion in 2026. That number tells you everything you need to know about the incentive structure behind what you read online about anti-aging pills. For every compound with genuine research behind it, there are dozens being marketed on the strength of a single mouse study, a celebrity endorsement, or a mechanistic argument that sounds compelling but has never been tested in humans.

This guide exists because you deserve better than that. If you are spending money on supplements with the goal of living longer and healthier, you should know which ones have real evidence, which ones are promising but early, and which ones are almost certainly wasting your money. The longevity space rewards bold claims. We are going to reward honest ones.

What follows is a tier-ranked breakdown of the most discussed longevity supplements, organized by the actual strength of their evidence in humans. Not in mice. Not in cell cultures. In people, in clinical trials, with measurable outcomes. Where the evidence is strong, we will say so. Where it is weak, speculative, or nonexistent, we will say that too. The goal is not to sell you a stack. It is to help you make rational decisions with your money and your health.

The supplement problem

Before we rank anything, it is worth understanding why the longevity supplement landscape is so difficult to navigate. The fundamental issue is a mismatch between the economics of supplement marketing and the economics of rigorous clinical research.

Running a proper randomized controlled trial (RCT) for a supplement costs millions of dollars and takes years. Most supplement ingredients are natural compounds that cannot be patented, which means there is no financial incentive for any company to fund definitive research. The result is a landscape dominated by small, short-duration studies with limited statistical power, often funded by supplement companies with obvious conflicts of interest. A study showing that resveratrol activates SIRT1 in a petri dish gets packaged into marketing copy that implies the supplement will extend your lifespan. The gap between those two claims is enormous, and it is filled almost entirely by marketing.

The second problem is dose translation. Many of the most compelling longevity results come from animal studies using doses that are not achievable with oral supplements. A mouse study showing dramatic lifespan extension with compound X at 500mg/kg body weight gets translated into a 250mg capsule for a 75kg human, at roughly 0.2% of the equivalent dose. This is not a minor detail. It is the difference between the intervention that actually produced results and the product sitting on your shelf. The supplement industry systematically obscures this distinction.

The third problem is outcome measurement. Longevity is, by definition, a decades-long outcome. No supplement RCT has ever run long enough to measure actual lifespan extension in humans. So researchers use surrogate endpoints: blood markers, inflammatory biomarkers, telomere length, epigenetic clocks. These are useful but imperfect proxies. A supplement that improves your blood lipids might or might not extend your life. We do not know, and anyone who tells you otherwise is speculating. That does not mean supplements are worthless. It means we need to be precise about what we actually know.

Tier 1: Strong evidence

These supplements have the most robust evidence base for health outcomes relevant to longevity. “Strong evidence” here means multiple large RCTs in humans, consistent positive results across studies, established mechanisms of action, and safety profiles that are well understood. These are not speculative. They are the foundation.

Omega-3 fatty acids (fish oil / EPA+DHA)

What it does: Omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are essential polyunsaturated fats that your body cannot produce on its own. They are structural components of cell membranes, precursors to anti-inflammatory signaling molecules called resolvins and protectins, and modulators of gene expression related to inflammation, lipid metabolism, and vascular function.

Evidence level: Among the strongest of any supplement. The REDUCE-IT trial (8,179 participants) demonstrated a 25% relative risk reduction in major cardiovascular events with high-dose EPA (4g/day icosapent ethyl). The VITAL trial (25,871 participants) found a significant reduction in heart attacks (28% reduction) and cardiovascular death, with the strongest effects in participants with low baseline fish consumption. Multiple meta-analyses of omega-3 trials consistently show reductions in triglycerides, cardiovascular mortality, and inflammatory markers including C-reactive protein and IL-6. The evidence for cognitive protection is more moderate but growing: higher omega-3 intake is associated with reduced rates of cognitive decline, and the omega-3 index (a measure of EPA+DHA in red blood cell membranes) is emerging as a meaningful biomarker of aging.

Dosing: 2 to 4 grams of combined EPA+DHA daily. Most general-purpose fish oil capsules contain 300mg of combined omega-3 per 1g capsule, so you need higher-concentration products to reach therapeutic doses without swallowing 10 pills. Look for products with at least 500mg combined EPA+DHA per capsule. Triglyceride-form fish oil has better absorption than ethyl-ester form. Take with a meal containing fat for optimal absorption.

Who benefits most: Virtually everyone, but especially those with low fish intake (fewer than 2 servings per week), elevated triglycerides, a family history of cardiovascular disease, or chronic inflammation. If your diet already includes substantial cold-water fatty fish (salmon, sardines, mackerel, herring) multiple times per week, supplementation is less critical but likely still beneficial at therapeutic doses.

Vitamin D3

What it does: Vitamin D3 (cholecalciferol) functions as a prohormone rather than a traditional vitamin. Once converted to its active form (1,25-dihydroxyvitamin D / calcitriol), it binds to vitamin D receptors found in virtually every tissue in the body, regulating the expression of over 1,000 genes involved in immune function, calcium metabolism, cell proliferation, muscle function, and inflammatory response.

Evidence level: Strong for deficiency correction, moderate-to-strong for broad health outcomes. The VITAL trial showed a 17% reduction in advanced cancer incidence with 2,000 IU daily vitamin D3 supplementation. A 2023 meta-analysis in the BMJ found that vitamin D supplementation reduced all-cause mortality by approximately 6% across pooled trials, with the greatest benefit in individuals who were deficient at baseline. Vitamin D insufficiency (below 30 ng/mL) affects an estimated 40% of adults in the United States and is significantly higher in northern latitudes, darker-skinned populations, and individuals who spend limited time outdoors. The relationship between low vitamin D and increased mortality, cardiovascular disease, cognitive decline, and immune dysfunction is robust and consistent across observational studies.

Dosing: 2,000 to 5,000 IU daily for most adults, adjusted based on blood levels. The target range for 25(OH)D levels is 40 to 60 ng/mL, which represents the range associated with the lowest all-cause mortality in observational data. Get your levels tested. Vitamin D is fat-soluble and accumulates, so dosing should be guided by blood work, not guesswork. Take with a fat-containing meal. Pair with vitamin K2 (MK-7 form, 100 to 200 mcg daily) to ensure proper calcium routing to bones rather than arteries.

Who benefits most: Anyone with levels below 40 ng/mL, which includes the majority of adults who do not get substantial sun exposure. If you live above the 37th parallel (roughly the latitude of San Francisco, Richmond, or Athens), work indoors, use sunscreen consistently, or have darker skin, you are almost certainly insufficient without supplementation.

Magnesium

What it does: Magnesium is a cofactor in more than 300 enzymatic reactions in the human body, including those involved in ATP production, DNA synthesis, protein synthesis, nerve transmission, muscle contraction, blood pressure regulation, and blood glucose control. It is the fourth most abundant mineral in the body and is essential for the function of every organ system.

Evidence level: Strong and underappreciated. A 2017 meta-analysis in the European Journal of Clinical Nutrition comprising over 1 million participants found that higher dietary magnesium intake was associated with significantly reduced risk of stroke, heart failure, type 2 diabetes, and all-cause mortality. A 2023 analysis found that each 100mg/day increase in magnesium intake was associated with a 10% reduction in heart failure risk and a 7% reduction in stroke risk. An estimated 50% of the U.S. population does not meet the recommended dietary allowance for magnesium, and subclinical magnesium deficiency (insufficient levels that do not produce obvious symptoms but impair metabolic function) is widespread. Magnesium supplementation has demonstrated improvements in blood pressure, insulin sensitivity, sleep quality, exercise performance, and inflammatory markers in randomized trials.

Dosing: 200 to 400 mg of elemental magnesium daily, depending on dietary intake. Not all forms are equivalent. Magnesium glycinate has good bioavailability and is well tolerated, with the added benefit of glycine (itself a longevity-relevant amino acid). Magnesium L-threonate crosses the blood-brain barrier and may have specific cognitive benefits. Magnesium citrate is inexpensive and well-absorbed but can cause loose stools at higher doses. Avoid magnesium oxide, which has very poor bioavailability (approximately 4%). Take in the evening, as magnesium has mild relaxation and sleep-supporting effects.

Who benefits most: Most adults. Magnesium is depleted by stress, alcohol, coffee, medications (especially proton pump inhibitors and diuretics), and processed food diets that are low in nuts, seeds, leafy greens, and whole grains. If you experience muscle cramps, poor sleep, anxiety, or irregular heart rhythms, magnesium deficiency is worth investigating before reaching for more exotic interventions.

Creatine monohydrate

What it does: Creatine is a naturally occurring compound found primarily in muscle and brain tissue. It serves as a rapid-access energy reserve by donating a phosphate group to regenerate ATP (the cellular energy currency) during high-intensity activity. Beyond its well-established role in exercise performance, creatine has emerged as a genuinely interesting longevity compound with benefits for muscle preservation, cognitive function, and cellular energy metabolism.

Evidence level: Strong for muscle preservation and exercise performance, growing for cognition and aging. Creatine is the most extensively studied sports supplement in history, with over 500 peer-reviewed publications. For longevity-relevant outcomes, the key evidence includes: significant preservation of lean muscle mass during aging (critical for preventing sarcopenia, one of the strongest predictors of all-cause mortality in older adults), improvements in cognitive function under conditions of sleep deprivation, metabolic stress, and aging, and potential neuroprotective effects through enhanced cellular energy availability in the brain. A 2022 systematic review found that creatine supplementation in older adults consistently improved upper and lower body strength, functional performance, and lean body mass, all of which directly correlate with reduced fall risk, disability, and mortality.

Dosing: 3 to 5 grams of creatine monohydrate daily. No loading phase is necessary. Monohydrate is the most studied form and the most cost-effective. Claims that other forms (HCl, ethyl ester, buffered) are superior are not supported by comparative evidence. Timing does not matter significantly, but post-workout may offer a slight advantage for muscle uptake. Take with water. Creatine causes a modest (1 to 3 pounds) initial weight gain from intracellular water retention, which is physiological and benign.

Who benefits most: Adults over 40 who are concerned about muscle loss and cognitive decline, vegetarians and vegans (who have lower baseline creatine stores since it is found primarily in animal tissue), and anyone engaged in resistance training. Creatine is remarkably inexpensive relative to its evidence base, typically $0.05 to $0.10 per day.

CoQ10 / Ubiquinol

What it does: Coenzyme Q10 is a molecule found in the mitochondrial membrane of every cell in the body. It plays a critical role in the electron transport chain, the final stage of cellular energy production where the majority of ATP is generated. CoQ10 also functions as a potent lipid-soluble antioxidant, protecting cell membranes and lipoproteins (including LDL) from oxidative damage. CoQ10 exists in two forms: ubiquinone (the oxidized form) and ubiquinol (the reduced, active form). Your body can convert between the two, but the efficiency of this conversion declines with age.

Evidence level: Strong for specific populations, moderate for general longevity. The Q-SYMBIO trial (420 patients with heart failure) demonstrated that CoQ10 supplementation at 300mg/day reduced cardiovascular mortality by 43% and all-cause mortality by 42% over 2 years. This is one of the most striking mortality reduction results in nutritional supplement research. The KiSel-10 trial showed that combined CoQ10 and selenium supplementation reduced cardiovascular mortality by 53% in elderly subjects over a 5-year period, with benefits persisting for 12 years after the study ended. For statin users, CoQ10 supplementation consistently reduces statin-induced myalgia (muscle pain) in clinical trials, which is relevant because statins inhibit the same biosynthetic pathway (mevalonate pathway) that produces both cholesterol and CoQ10. CoQ10 levels in tissues decline with age, and supplementation restores mitochondrial function markers in older adults.

Dosing: 100 to 300mg daily. Ubiquinol (the reduced form) has approximately 2x the bioavailability of ubiquinone and is generally recommended, particularly for adults over 40 whose conversion efficiency has declined. Take with a fat-containing meal, as CoQ10 is highly lipophilic and absorption increases substantially with dietary fat. For statin users, 200 to 300mg daily is a reasonable starting dose to counteract CoQ10 depletion.

Who benefits most: Adults over 40, anyone taking a statin, individuals with a history of cardiovascular disease or heart failure, and those experiencing fatigue that may be related to mitochondrial dysfunction. CoQ10 is one of the few supplements where the combination of mechanism, clinical trial data, and safety profile makes a genuinely compelling case for broad use in aging adults.

Tier 2: Promising evidence

These supplements have legitimate scientific rationale and encouraging preliminary data, but the evidence is not yet strong enough to put them in the same category as the Tier 1 compounds. In many cases, the mechanism is well understood, the animal data is impressive, and human trials are ongoing or recently completed. “Promising” means worth paying attention to, potentially worth taking, but with appropriate expectations about uncertainty.

NMN and NR (NAD+ precursors)

What it does: Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are precursor molecules that your body uses to synthesize NAD+, the coenzyme critical for energy metabolism, DNA repair, sirtuin activation, and hundreds of other cellular processes. NAD+ levels decline significantly with age, and replenishing them through precursor supplementation is one of the most actively researched strategies in longevity science. Both NMN and NR enter the NAD+ salvage pathway, though at different points, and both have been shown to raise NAD+ levels in human blood and tissues. For a deeper exploration of NAD+ biology and direct IV delivery, see our complete NAD+ IV therapy guide.

Evidence level: Moderate and rapidly evolving. Animal studies are impressively consistent: NMN and NR supplementation in aged mice improves vascular function, insulin sensitivity, exercise capacity, cognitive performance, and mitochondrial function. The human data is growing but still limited in scope. Multiple RCTs have confirmed that NMN and NR supplementation raises blood NAD+ levels in humans by 40 to 90%, with some variability based on dose and form. However, whether the increase in NAD+ levels translates to the same functional benefits seen in animal models is still being established. A 2023 RCT of NMN (1,000mg/day) in middle-aged men showed improved arterial stiffness and reduced biological age as measured by epigenetic clocks. Another RCT found improved walking endurance in older adults. These are encouraging, but we need larger, longer trials with clinical endpoints.

Dosing: NMN: 500 to 1,000mg daily. NR: 300 to 1,000mg daily. Both are typically taken in the morning. The NMN vs. NR debate is ongoing, with some researchers arguing that NMN is more efficiently converted to NAD+ in certain tissues, while NR has a longer track record of human safety data (Niagen, the branded form of NR, has been granted GRAS status by the FDA). Both are reasonable choices given current evidence.

Who benefits most: Adults over 40 experiencing age-related decline in energy, cognitive sharpness, or exercise recovery. Those with low baseline NAD+ levels (which can be tested, though testing is not yet standardized or widely available). NMN and NR represent a lower-cost, more accessible alternative to NAD+ IV therapy, though the bioavailability and tissue penetration of oral precursors is lower than direct IV delivery.

Berberine

What it does:Berberine is an alkaloid found in several plants (goldenseal, Oregon grape, barberry) that activates AMPK (AMP-activated protein kinase), a master metabolic regulator sometimes called the body's “metabolic switch.” AMPK activation mimics many of the metabolic effects of exercise and caloric restriction, including improved glucose uptake, enhanced fatty acid oxidation, reduced hepatic gluconeogenesis, and increased mitochondrial biogenesis. Berberine also modulates the gut microbiome and has anti-inflammatory properties.

Evidence level: Moderate-to-strong for metabolic outcomes. Multiple RCTs have shown that berberine at 1,500mg/day reduces fasting blood glucose and HbA1c to a degree comparable to metformin in type 2 diabetics. A meta-analysis of 27 clinical trials found significant reductions in fasting glucose, HbA1c, triglycerides, and LDL cholesterol. The metabolic improvements are real and well-documented. The longevity relevance is indirect but compelling: metabolic dysfunction (insulin resistance, hyperglycemia, dyslipidemia) is one of the strongest drivers of accelerated aging and age-related disease. By improving metabolic health, berberine likely reduces the downstream burden of metabolic aging. However, no long-term trials have directly measured lifespan or healthspan outcomes.

Dosing: 500mg two to three times daily (1,000 to 1,500mg total), taken with meals. Berberine has limited bioavailability, and some newer formulations (dihydroberberine, liposomal berberine) claim improved absorption, though comparative human data is sparse. Cycling (8 weeks on, 4 weeks off) is commonly recommended to avoid potential gut microbiome disruption with continuous use, though this recommendation is based on precaution rather than strong evidence of harm.

Who benefits most: Individuals with prediabetes, insulin resistance, elevated fasting glucose, or metabolic syndrome. If your fasting glucose is consistently above 90 mg/dL, your HbA1c is above 5.4%, or you carry excess visceral fat, berberine is worth considering as a metabolic optimization tool. It is not a substitute for exercise and dietary changes but may augment their effects.

Curcumin (turmeric extract)

What it does:Curcumin is the primary bioactive compound in turmeric, with potent anti-inflammatory and antioxidant properties. It modulates NF-kB (a master inflammatory transcription factor), inhibits COX-2 and LOX enzymes, reduces production of inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), and activates Nrf2, a transcription factor that upregulates the body's endogenous antioxidant defenses.

Evidence level: Moderate. The anti-inflammatory effects of curcumin are well established in human trials. A 2021 meta-analysis of 32 RCTs found significant reductions in CRP, IL-6, and TNF-alpha with curcumin supplementation. Individual trials have shown improvements in joint pain comparable to NSAIDs (without the gastrointestinal side effects), modest improvements in depressive symptoms, and reductions in markers of oxidative stress. The longevity relevance stems from the strong mechanistic link between chronic inflammation (inflammaging) and age-related disease. By reducing systemic inflammation, curcumin may slow the accumulation of inflammatory damage that drives cardiovascular disease, neurodegeneration, and metabolic dysfunction. The main caveat is bioavailability: curcumin is poorly absorbed on its own, and the clinical results are only achieved with enhanced formulations.

Dosing: 500 to 1,000mg daily of an enhanced-bioavailability formulation. Standard turmeric powder or unformulated curcumin has essentially zero bioavailability and is not worth supplementing for systemic effects. Look for formulations with piperine (black pepper extract, which increases absorption by approximately 2,000%), phytosome technology (Meriva), or nanoparticle technology (Theracurmin). Take with a fat-containing meal.

Who benefits most: Individuals with chronic low-grade inflammation (elevated hs-CRP), joint pain or stiffness, or a family history of inflammatory conditions. Curcumin is particularly relevant for people who want anti-inflammatory benefits without the long-term risks of NSAIDs.

Ashwagandha (Withania somnifera)

What it does: Ashwagandha is an adaptogenic herb that modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol production and buffering the physiological stress response. It also has demonstrated effects on thyroid function, testosterone levels, exercise performance, and sleep quality. The longevity relevance is primarily through stress pathway modulation: chronic elevated cortisol accelerates aging through immune suppression, muscle wasting, bone loss, cognitive impairment, and metabolic dysfunction.

Evidence level: Moderate. Multiple RCTs have demonstrated significant cortisol reductions (14 to 28% in various studies), improvements in perceived stress and anxiety, and improvements in sleep quality. A 2023 meta-analysis found consistent and significant anxiolytic effects. For physical performance, RCTs have shown modest increases in VO2 max, strength, and recovery. Testosterone studies show small but statistically significant increases in men (primarily those with stress-related suppression rather than primary hypogonadism). The compound has a long history of use in Ayurvedic medicine and a strong safety record in clinical trials of up to 12 weeks duration.

Dosing: 300 to 600mg daily of a standardized root extract (KSM-66 and Sensoril are the two most clinically studied extracts). Take in the evening, as the cortisol-lowering and sleep-supporting effects are most relevant at night. Effects typically become noticeable after 4 to 8 weeks of consistent use.

Who benefits most: Individuals with elevated cortisol, chronic stress, anxiety, poor sleep quality, or stress-related hormonal disruption. Not recommended for those with hyperthyroidism or autoimmune thyroid conditions, as ashwagandha can stimulate thyroid function. For a broader look at hormone optimization strategies, ashwagandha fits within the stress management and adrenal support category.

Spermidine

What it does: Spermidine is a naturally occurring polyamine that declines with age. Its primary longevity-relevant mechanism is the induction of autophagy, the cellular recycling process that clears damaged proteins, dysfunctional mitochondria, and cellular debris. Autophagy is one of the most fundamental cellular maintenance mechanisms, and its decline with age contributes to the accumulation of damage that drives aging and age-related disease.

Evidence level: Moderate and rapidly growing. In animal studies, spermidine supplementation has consistently extended lifespan across multiple organisms (yeast, flies, worms, mice) by 10 to 25%. In mice, it improved cardiac function, reduced neuroinflammation, and enhanced memory. The human data is more limited but encouraging. The Bruneck prospective cohort study (over 800 participants followed for 20 years) found that higher dietary spermidine intake was associated with significantly reduced all-cause mortality, cardiovascular mortality, and cancer mortality, with a dose-response relationship. A 2021 RCT found that spermidine supplementation improved memory performance in older adults at risk for dementia. The epidemiological association between spermidine intake and longevity is remarkably consistent. For more on how autophagy supports longevity, see our complete autophagy guide.

Dosing: 1 to 6mg daily. Dietary sources rich in spermidine include aged cheese, wheat germ, soybeans, mushrooms, and fermented foods. Supplement forms are available but purity and standardization vary. Because spermidine is a relatively new supplement ingredient, third-party testing is especially important. Effects work through the same autophagy pathways activated by fasting, caloric restriction, and exercise, making spermidine a potential pharmacological mimic of these proven longevity interventions.

Who benefits most: Older adults (spermidine levels decline significantly with age), individuals interested in autophagy optimization who find extended fasting difficult to maintain, and those with a family history of neurodegenerative disease given the preliminary cognitive benefits.

Tier 3: Interesting but early

These compounds have compelling mechanistic rationale and exciting preclinical data, but the human evidence is too early to make confident recommendations. They represent the frontier of longevity supplementation. Some of them will likely move to higher tiers as research matures. Others may not survive rigorous human testing. Watch them. Do not build your supplement strategy around them.

Fisetin and quercetin (senolytics)

What they do:Fisetin and quercetin are plant flavonoids that have demonstrated senolytic activity, meaning they selectively clear senescent (“zombie”) cells that accumulate with age and secrete inflammatory factors that damage surrounding tissue. Senescent cell accumulation is now considered one of the hallmarks of aging, and clearing them has produced some of the most dramatic results in preclinical longevity research.

Evidence level: Strong in animals, very early in humans. Fisetin in particular has shown remarkable senolytic potency in mouse studies, extending lifespan and restoring function in aged animals. The combination of dasatinib and quercetin (D+Q) was the first senolytic protocol demonstrated to clear senescent cells in humans (Kirkland et al., 2019, at the Mayo Clinic). However, large-scale human RCTs measuring functional outcomes are still underway. The AFFIRM trial for fisetin in COVID-related conditions showed safety but mixed efficacy results. Several trials at the Mayo Clinic and other institutions are ongoing for idiopathic pulmonary fibrosis, osteoarthritis, and kidney disease. For a comprehensive breakdown of the senolytic research and available protocols, see our complete senolytics guide.

Dosing: Senolytic protocols use intermittent high-dose approaches (not daily low-dose). Fisetin: approximately 20mg/kg body weight for 2 consecutive days per month. Quercetin: typically used in combination with dasatinib (500mg quercetin + 50mg dasatinib) for 3 consecutive days followed by several weeks off. Daily low-dose quercetin (500mg) may provide anti-inflammatory benefits but likely does not achieve meaningful senolytic effects.

Who benefits most: This is an area to watch rather than act on aggressively without medical guidance. Older adults with high senescent cell burden (correlated with age, obesity, and chronic disease) are the population most likely to benefit. If you are interested in senolytics, work with a longevity-focused physician who can guide protocol design and monitor outcomes.

Rapamycin (context)

What it does: Rapamycin (sirolimus) is an mTOR inhibitor originally developed as an immunosuppressant for organ transplant recipients. mTOR (mechanistic target of rapamycin) is a master regulator of cell growth, protein synthesis, and autophagy. Inhibiting mTOR with rapamycin mimics some of the longevity benefits of caloric restriction, including enhanced autophagy, improved mitochondrial function, reduced inflammation, and altered immune function.

Evidence level: Rapamycin is arguably the most consistently life-extending compound ever tested in mammalian models. The NIA Interventions Testing Program found significant lifespan extension in mice across multiple independent laboratories, with effects in both sexes. It has extended lifespan in every organism tested, from yeast to mice. However, rapamycin is a prescription drug with genuine immunosuppressive effects, and translating the animal results to human longevity protocols requires careful dosing to balance benefits against risks. A small but growing number of longevity physicians prescribe low-dose, intermittent rapamycin (typically 3 to 6 mg once per week, rather than the daily higher doses used for transplant patients), and early human data suggests this dosing pattern may actually enhance rather than suppress certain immune functions. The PEARL trial and other human studies are underway.

Important: Rapamycin is not a supplement. It is a prescription pharmaceutical with real side effects and drug interactions. Do not self-source or self-dose. If you are interested in rapamycin for longevity, find a qualified physician who understands the emerging literature on low-dose intermittent protocols. This is included here for completeness because it is among the most discussed longevity compounds, but it belongs in a fundamentally different category from over-the-counter supplements.

Alpha-ketoglutarate (AKG)

What it does: AKG is a key intermediate in the Krebs cycle (the metabolic cycle that produces cellular energy) and a cofactor for multiple enzymes involved in epigenetic regulation, collagen synthesis, and amino acid metabolism. AKG levels decline with age, and supplementation in animal models has shown intriguing longevity effects.

Evidence level: Early but interesting. A 2020 study in Cell Metabolism found that calcium AKG supplementation in middle-aged mice extended median lifespan by 12% in females and reduced biological age markers (frailty index) by 46%. A pilot human trial using a proprietary AKG formulation (Rejuvant) reported significant reductions in biological age as measured by DNA methylation clocks (approximately 8 years of epigenetic age reversal over 7 months). These results are intriguing but should be interpreted cautiously: the human trial was small, open-label, and conducted by the company selling the product. Larger, independent RCTs are needed.

Dosing: 1,000mg of calcium alpha-ketoglutarate (Ca-AKG) daily, typically in divided doses. This is the form used in the published studies. AKG from other sources may differ in bioavailability and effect.

Pterostilbene

What it does: Pterostilbene is a methylated analogue of resveratrol found naturally in blueberries and grapes. It activates SIRT1 and other sirtuins, has antioxidant properties, and modulates lipid metabolism. Critically, pterostilbene has approximately 4x the bioavailability of resveratrol, which partially addresses the major pharmacokinetic limitation that undermines resveratrol supplementation.

Evidence level: Early. Animal studies show improvements in cognitive function, lipid profiles, and blood pressure. A 2014 RCT in humans found that pterostilbene at 250mg/day significantly reduced blood pressure and improved lipid profiles. However, the human data is limited to small, short-duration studies. Pterostilbene is included in Tier 3 rather than Tier 2 because, despite its superior bioavailability relative to resveratrol, the body of human clinical evidence is not yet sufficient to make confident recommendations. It remains a potentially useful SIRT1 activator that warrants attention as more data emerges.

What does not work (or is overhyped)

Being honest about what does not work is as important as identifying what does. The following categories consistently underperform their marketing claims, and spending money on them likely diverts resources from interventions with actual evidence.

Most anti-aging pill blends

Products marketed as comprehensive “anti-aging formulas” or “longevity stacks” that combine 15 to 30 ingredients at sub-therapeutic doses are, in nearly all cases, marketing constructs rather than evidence-based interventions. The typical pattern: take a list of compounds that have individually shown some promise in isolated studies, include each one at a fraction of the dose used in those studies, package them together, and market the blend as synergistic. There is rarely any clinical evidence for the specific combination at the specific doses in the product. You are paying a premium for a proprietary blend that delivers inadequate amounts of multiple ingredients. Build your own stack from individual, properly dosed ingredients based on your specific needs. It is cheaper, more effective, and more transparent.

Resveratrol at supplement doses

This is perhaps the most controversial entry on this list, because resveratrol is one of the most widely recognized longevity compounds thanks to David Sinclair's influential research. The problem is not the molecule. The problem is the dose. The landmark studies showing lifespan extension and metabolic benefits in mice used resveratrol at doses equivalent to several grams per day in a human, typically 100 to 400mg/kg in mice. A standard resveratrol supplement contains 250 to 500mg per capsule. For a 75kg human, the mouse-equivalent dose would be approximately 1,200 to 4,800mg daily, accounting for interspecies dose scaling. Even at these high doses, a large clinical trial (REFRAME) found no significant cardiovascular or metabolic benefits of resveratrol in older adults. Further compounding the issue, resveratrol has poor oral bioavailability, with extensive first-pass metabolism resulting in less than 1% reaching circulation in its active form. Multiple human RCTs at supplement doses (250 to 1,000mg) have produced inconsistent results, with several large trials showing no significant benefit on cardiovascular markers, glycemic control, or inflammatory biomarkers. Resveratrol may have genuine biological activity at pharmacological doses, but the 250mg capsule you are buying is very unlikely to replicate the effects seen in mouse studies.

Colloidal minerals and trace mineral complexes

Colloidal mineral supplements (colloidal silver, colloidal gold, humic/fulvic acid mineral complexes) are marketed for longevity on the basis of vague claims about “cellular detoxification,” “electron donation,” and “mineral replenishment.” There is essentially zero clinical evidence supporting any longevity benefit from these products. Colloidal silver has been associated with argyria (irreversible skin discoloration) and can interfere with antibiotic absorption. The mineral content of these products is poorly standardized and often contains elements you do not want to be ingesting. If you have a specific mineral deficiency, supplement that specific mineral in its properly bioavailable form. There is no evidence that a shotgun approach of trace minerals in colloidal suspension provides any health benefit.

Multi-ingredient “longevity stacks” with no evidence

The supplement industry has identified “longevity” as a premium market segment and responded by creating expensive proprietary formulations with names that evoke science and aging research. Many of these products cost $80 to $200 per month and combine ingredients like NMN, resveratrol, quercetin, PQQ, and various plant extracts at undisclosed or sub-therapeutic doses. The marketing typically references “the latest research” without specifying which research, at what dose, and whether the research was conducted in humans or in cell cultures. The price premium is for the brand, the bottle design, and the influencer partnership, not for superior formulation. If you want these ingredients, buy them individually from reputable manufacturers, at doses supported by actual research, and save 50 to 70% compared to branded longevity stacks.

The foundation matters more

This section is the most important in the entire article, and it is the one most supplement companies hope you will skip. No supplement will meaningfully extend your life if the foundational behaviors are not in place. This is not a motivational platitude. It is a quantitative reality.

Exercise is the single most evidence-supported longevity intervention available. A meta-analysis of over 1.3 million participants found that regular physical activity reduces all-cause mortality by 30 to 35%. No supplement comes close to this effect size. Specifically, a combination of resistance training (which preserves muscle mass, bone density, and metabolic function) and cardiovascular exercise (which improves cardiac output, vascular health, and VO2 max) addresses multiple hallmarks of aging simultaneously. VO2 max is one of the strongest independent predictors of all-cause mortality, and it is trainable at any age. If you are spending $200 per month on supplements but not exercising regularly, your priorities are inverted.

Sleep quality and duration directly affect nearly every longevity-relevant biomarker. Chronic sleep restriction (fewer than 7 hours) is associated with increased all-cause mortality, accelerated cognitive decline, impaired immune function, elevated cortisol, insulin resistance, and accelerated biological aging. Addressing brain fog and cognitive symptoms often starts with fixing sleep rather than adding supplements.

Nutrition provides the substrate for every cellular process that supplements claim to support. A whole-food diet rich in vegetables, fruit, lean protein, healthy fats, and fiber provides magnesium, omega-3s, polyphenols, antioxidants, and fiber in bioavailable forms alongside thousands of micronutrients and phytochemicals that supplements cannot replicate. The Mediterranean diet pattern has more epidemiological evidence for longevity than any single supplement.

Stress management matters because chronic cortisol elevation drives immunosenescence, muscle catabolism, visceral fat accumulation, neurodegeneration, and systemic inflammation. These are not abstract mechanisms. They are measurable, accelerate biological aging, and are directly mitigated by meditation, social connection, nature exposure, and other stress-reduction practices.

Hormone optimization becomes increasingly relevant after 40, when declines in testosterone, estrogen, progesterone, DHEA, growth hormone, and thyroid function contribute to loss of muscle, bone, cognitive function, and vitality. For a detailed look at these pathways, see our hormone optimization guide. DHEA in particular is a widely used over-the-counter longevity supplement with specific considerations covered in our DHEA supplement guide.

Supplements build on this foundation. Without it, they are noise. A well-optimized supplement stack on top of poor sleep, no exercise, a processed food diet, and chronic stress is like putting premium fuel in a car with no engine. Fix the foundation first. Then add supplements strategically.

A practical longevity supplement stack

Based on the evidence reviewed above, here is a practical, tiered approach to longevity supplementation. Start with the basics. Only move to intermediate and advanced tiers if the foundation is solid and the basics are in place.

Basic stack (highest evidence, lowest risk)

Total cost: approximately $38 to $70 per month. This basic stack addresses the most common nutrient gaps in modern diets, supports cardiovascular health, metabolic function, muscle preservation, cognitive function, and bone health. Every component has strong evidence, excellent safety, and is remarkably inexpensive relative to its benefit. If you do nothing else in the supplement space, do this.

Intermediate stack (add to basic)

Additional cost: approximately $50 to $100 per month. The intermediate tier adds NAD+ precursor support and mitochondrial optimization. This makes sense for adults over 40 who have the basic stack dialed in, are already exercising and sleeping well, and want to target cellular energy and repair pathways more aggressively. CoQ10 is especially important if you take a statin.

Advanced stack (add to intermediate)

Additional cost: approximately $45 to $75 per month. The advanced tier targets senescent cell clearance and autophagy optimization. These interventions are based on strong mechanistic rationale and impressive animal data, but human evidence is still accumulating. This tier is appropriate for individuals who are already optimized across the basic and intermediate stacks, have their lifestyle foundation dialed in, and accept the higher uncertainty in exchange for potential early-mover advantage on emerging longevity interventions. Consider working with a longevity-focused physician if you are implementing senolytic protocols.

Frequently asked questions

Are longevity supplements worth it?

It depends entirely on which supplements and what you mean by “worth it.” The Tier 1 supplements (omega-3, vitamin D, magnesium, creatine, CoQ10) address common deficiencies and have robust clinical evidence for health outcomes that are directly relevant to aging and disease risk. For $40 to $70 per month, the risk-reward ratio is compelling. These are not exotic longevity compounds. They are foundational nutrients and cofactors that most adults are not getting enough of through diet alone. The Tier 2 and Tier 3 supplements involve more uncertainty and higher cost. Whether they are “worth it” depends on your risk tolerance, budget, and the degree to which your lifestyle foundation is already optimized. If you are not exercising, sleeping well, and eating a nutrient-dense diet, spending $150 per month on NMN and fisetin is not a rational allocation of resources. Fix the foundation first.

NMN vs. NR: which is better?

There is no definitive answer yet, and anyone who tells you one is clearly superior is overstating the evidence. Both are NAD+ precursors that have been shown to raise blood NAD+ levels in human trials. NMN enters the NAD+ salvage pathway one step closer to NAD+ (NMN is directly converted to NAD+ by the enzyme NMNAT), while NR must first be converted to NMN before becoming NAD+. Some researchers argue this makes NMN more direct and efficient. Others point out that NMN may need to be converted to NR to cross cell membranes before being reconverted to NMN intracellularly (via the transporter SLC12A8 or the ectoenzyme CD73). NR (as Niagen) has more established human safety data and FDA GRAS status. NMN has more recent clinical trials showing functional benefits. Both are reasonable choices. If forced to choose, NMN at 500mg daily or NR at 300mg daily are well-supported starting doses. For direct NAD+ delivery that bypasses the conversion question entirely, see NAD+ IV therapy.

What supplements does Bryan Johnson take?

Bryan Johnson's Blueprint protocol is one of the most publicly documented longevity supplement regimens in existence. As of early 2026, his published stack includes (among many other compounds) NMN, lithium orotate, ashwagandha, garlic extract, glucosamine, metformin, EPA/DHA, vitamin D, and various other compounds totaling over 50 daily supplements at a reported cost of over $2,000 per month. Johnson's approach is maximalist and highly individualized, guided by continuous biomarker monitoring and a dedicated medical team. The results he reports on biological age reversal are interesting but represent an n=1 experiment that cannot be generalized. Copying his exact stack without his monitoring infrastructure, medical oversight, and lifestyle adherence (he also follows strict caloric restriction, an optimized exercise protocol, and rigorous sleep optimization) would be both expensive and potentially counterproductive. Take inspiration from his commitment to measurement and experimentation. Do not blindly replicate his pill stack.

Can supplements replace exercise for longevity?

No. This is not a matter of opinion or a question where more research might change the answer. No supplement has ever demonstrated the breadth and magnitude of longevity benefit that regular exercise provides. Exercise simultaneously improves cardiovascular function, VO2 max (one of the strongest predictors of all-cause mortality), insulin sensitivity, mitochondrial biogenesis, muscle mass preservation, bone density, immune function, cognitive health, and emotional well-being. It clears senescent cells, activates autophagy, boosts NAD+ levels, reduces inflammation, and improves hormonal profiles. A single intervention that addresses all of those mechanisms would be considered the greatest pharmaceutical breakthrough in history. That intervention already exists, and it is free. Supplements can complement exercise. They cannot replace it. If you have to choose between a $200/month supplement stack and a gym membership, choose the gym membership. It is not close.

How long until you see results from longevity supplements?

This depends on the supplement and what you are measuring. Magnesium can improve sleep quality within days to weeks. Creatine produces measurable strength and performance improvements within 2 to 4 weeks. Omega-3 supplementation takes 4 to 8 weeks to significantly shift the omega-3 index and begin affecting inflammatory markers. NMN/NR typically raises blood NAD+ levels within 2 to 4 weeks, though functional benefits (energy, cognition, recovery) may take 4 to 12 weeks to become subjectively noticeable. CoQ10 may take 4 to 12 weeks to produce noticeable effects on energy levels, particularly in those who are deficient. For the deeper longevity-relevant outcomes (biological age reversal, reduced disease risk, extended healthspan), the honest answer is that we do not know the timeline with precision. These are interventions you take consistently over years and decades, and their value compounds over time in ways that are not captured by short-term subjective experience. Take them because the evidence supports them, not because you expect to feel dramatically different next Tuesday.